Antiva Biosciences Company

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection. The company's medicinal chemistry platform focuses on the development and commercialization of direct-acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV, and animal retroviruses, enabling patients to recover from HPV-related diseases and other viruses.
Technology: Cancer
Industry: General Health Care
Headquarters: Del Mar, California, United States
Founded Date: 2012
Employees Number: 11-50
Funding Status: Late Stage Venture
Total Funding: $56 346 025
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-07-10
Last Funding Type: Series C

Visit Website
Register and Claim Ownership